Literature DB >> 11282256

Striatal dopaminergic and serotonergic markers in human heroin users.

S J Kish1, K S Kalasinsky, P Derkach, G A Schmunk, M Guttman, L Ang, V Adams, Y Furukawa, J W Haycock.   

Abstract

To establish whether chronic opiate exposure might impair brain dopaminergic or serotonergic function in humans, we assessed biochemical indices of monoaminergic neurotransmitter activity and integrity in post mortem striatum of nine chronic heroin users and 14 control subjects. Striatal levels of the vesicular monoamine transporter were normal, suggesting that the density of dopamine nerve terminals is not reduced in heroin users. In nucleus accumbens, levels of tyrosine hydroxylase protein (-25%) and those of the dopamine metabolite homovanillic acid (-33%) were reduced significantly together with a trend for decreased dopamine (-32%) concentration. These changes could reflect either a compensatory downregulation of dopamine biosynthesis in response to prolonged dopaminergic stimulation caused by heroin, or reduced axoplasmic transport of tyrosine hydroxylase. Striatal levels of serotonin were either normal or elevated whereas concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid were decreased by 27-38%. Our data suggest that chronic heroin exposure might produce a modest reduction in dopaminergic and serotonergic activity that could affect motivational state and impulse control, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282256     DOI: 10.1016/S0893-133X(00)00209-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  31 in total

1.  A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.

Authors:  Marco Leyton; Valerie Kwai Pun; Chawki Benkelfat; Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

2.  Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study.

Authors:  Kelly P Cosgrove; Karen Tellez-Jacques; Brian Pittman; Ismene Petrakis; Ronald M Baldwin; Gilles Tamagnan; John Seibyl; Thomas Kosten; Julie K Staley
Journal:  Psychiatry Res       Date:  2010-11-03       Impact factor: 3.222

3.  Emotion, decision-making and substance dependence: a somatic-marker model of addiction.

Authors:  A Verdejo-García; M Pérez-García; A Bechara
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 4.  A somatic marker theory of addiction.

Authors:  Antonio Verdejo-García; Antoine Bechara
Journal:  Neuropharmacology       Date:  2008-08-05       Impact factor: 5.250

5.  Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study.

Authors:  Tzung Lieh Yeh; Kao Chin Chen; Shih-Hsien Lin; I Hui Lee; Po See Chen; Wei Jen Yao; Sheng-Yu Lee; Yen Kuang Yang; Ru-Band Lu; Mei-Hsiu Liao; Nan-Tsing Chiu
Journal:  Psychopharmacology (Berl)       Date:  2011-09-01       Impact factor: 4.530

6.  Longitudinal changes of dopamine transporters in heroin users during abstinence.

Authors:  Shasha Xu; Ying Liu; Yu Li; Yangping Deng; Yiyun Huang; Jie Yuan; Rongbin Lv; Yuankai Wang; Guangming Zhang; Zhirui Guo; Mei Han; Xingdang Liu; Daxu Fu
Journal:  Psychopharmacology (Berl)       Date:  2015-06-23       Impact factor: 4.530

Review 7.  Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.

Authors:  James P Harris; Justin C Burrell; Laura A Struzyna; H Isaac Chen; Mijail D Serruya; John A Wolf; John E Duda; D Kacy Cullen
Journal:  NPJ Parkinsons Dis       Date:  2020-01-08

8.  Serotonin transporter protein in autopsied brain of chronic users of cocaine.

Authors:  Junchao Tong; Jeffrey H Meyer; Isabelle Boileau; Lee-Cyn Ang; Paul J Fletcher; Yoshiaki Furukawa; Stephen J Kish
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

9.  Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.

Authors:  Zheng Yang; Yong-cong Shao; Shi-jiang Li; Jian-lin Qi; Mei-jie Zhang; Wei Hao; Guo-zhang Jin
Journal:  Acta Pharmacol Sin       Date:  2008-07       Impact factor: 6.150

10.  Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.

Authors:  Ying Liu; Mei Han; Xingdang Liu; Yanping Deng; Yu Li; Jie Yuan; Rongbin Lv; Yuankai Wang; Guangming Zhang; Jinlong Gao
Journal:  Psychopharmacology (Berl)       Date:  2013-05-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.